Research Article

Proinflammatory and Prothrombotic State in Subjects with Different Glucose Tolerance Status before Cardiovascular Disease

Table 1

Demographic and clinical characteristics of the overall sample categorized according to glucose tolerance status.

Total = 939 individuals
ParameterNGT
(50.4%)
Pre-DM
(26.6%)
T2DM
(23%)

Age (years)
 Mean ± SD
 Median IQR 50 40–58 52 45–59 57 49–62
Women, n (%)328 (69.3)168 (67.2)142 (65.7)
BMI (kg/m2)
 Mean ± SD
 Median IQR 27.5 24.7–31 29 26.1–31.7 29.6 26.8–32.8
BMI ≥ 30 kg/m2, n (%)150 (31.7)99 (39.6)102 (47.2)*
WC (cm)
 Mean ± SD
 Median IQR 91 82–99 95 89–102 98 91-105
Hypertension, n (%)137 (28.9)77 (30.8)117 (54.1)*†
Currents smoking, n (%)107 (22.6)48 (19.2)48 (22.2)
FH of T2DM, n (%)234 (49.4)146 (58.4)147 (68)*
FH of CVD, n (%)71 (15)38 (15.2)34 (15.7)

Data are means ± standard deviation, median [interquartile range], and percentages; * value ≤ 0.05 versus NGT; P value ≤ 0.05 versus pre-DM; NGT: normal glucose tolerance; pre-DM: pre-diabetes mellitus; T2DM: type 2 diabetes mellitus; BMI: body mass index; WC: waist circumference; FH of T2DM: familial history of type 2 diabetes mellitus; FH of CVD: familial history of cardiovascular disease.